ERBB2 and neoplasm: Furthermore, it was noted that anti-HER2 directed therapy given based on the HER2 status of the LMD tumor reduced the number of CSF tumor cells, which was associated with a positive clinical response to therapy (assessed via MRI, cytology and clinical evaluation).